Related Experiment Video
Updated: May 5, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
[Analgesics, antipyretics and non-steroidal anti-inflammatory drugs in pediatric prescriptions]
Insights
Most pediatric prescriptions for pain relievers and anti-inflammatory drugs lack regulatory approval and evidence. Over 95% of these prescriptions, in both public and private sectors, contain errors in dosage, frequency, or duration.
Area of Science:
- Pediatric pharmacology
- Drug utilization research
- Evidence-based medicine
Context:
- Analgesic, antipyretic, and non-steroidal anti-inflammatory drugs (NSAIDs) are frequently used in children.
- Pediatric drug prescriptions are often influenced by factors undermining rational use.
- Regulatory agency approval and scientific evidence do not always support common pediatric drug use.
Purpose:
- To evaluate the utilization of analgesic, antipyretic, and NSAIDs in children within both public (Unified Health System - SUS) and private (Non-SUS) healthcare sectors.
- To assess the appropriateness of drug prescriptions based on age, dosage, frequency, and duration of treatment.
- To identify differences or similarities in prescribing patterns between public and private healthcare settings.
Summary:
- A study analyzed 150 pediatric prescriptions (101 SUS, 49 Non-SUS) and interviewed caregivers across 18 locations.
- Appropriate age-based prescribing occurred in only 21.8% (SUS) and 29.6% (Non-SUS) of cases.
- Over 95% of all prescriptions exhibited errors in dosage, frequency, or duration, failing to meet rational use criteria.
Impact:
- Findings indicate widespread issues with rational drug use for common pediatric medications.
- There are no significant differences in prescription quality between public and private sectors.
- Highlights the need for improved guidelines and education for healthcare providers prescribing these medications to children.
Abstract:
The use of analgesic, antipyretic and non-steroidal anti-inflammatory drugs by children more often than not neither have the approval of regulatory agencies nor the endorsement of scientific evidence. Pediatric prescriptions can be influenced by factors that do not promote the rational use of drugs by this category. The objective of this study was to evaluate the use of analgesic, antipyretic and non-steroidal anti-inflammatory drugs in children, considering the public (SUS) and private (N-SUS) sectors. The sample comprised 150 prescriptions (101 SUS and 49 Non-SUS) followed by interviews with the caregivers in eighteen locations (nine private drugstores and nine units of the Unified Health System (SUS). The drugs were prescribed appropriately, by age group, only in 21.8% (SUS) and 29.6% (Non-SUS) prescriptions. Over 95% of prescription, regardless of source, did not meet the established criteria for evaluation of their rational use, with dosage, frequency and duration of treatment errors. The analysis of prescriptions for analgesic, antipyretic and non-steroidal anti-inflammatory drugs for children revealed no significant differences between the public and private sectors.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Dosing: Infants and Children
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Methods of reducing fever
Pharmacological Methods of Reducing Fever:

